Mitochondrial dysfunction, oxidative stress, neuroinflammation, and metabolic alterations in the progression of Alzheimer's disease: A meta-analysis of in vivo …

T Song, X Song, C Zhu, R Patrick, M Skurla… - Ageing research …, 2021 - Elsevier
Accumulating evidence demonstrates that metabolic changes in the brain associated with
neuroinflammation, oxidative stress, and mitochondrial dysfunction play an important role in …

Oxidative stress in neurodegenerative diseases: from a mitochondrial point of view

G Cenini, A Lloret, R Cascella - Oxidative medicine and …, 2019 - Wiley Online Library
Age is the main risk factor for a number of human diseases, including neurodegenerative
disorders such as Alzheimer's disease, Parkinson's disease, and amyotrophic lateral …

Mitochondrial dysfunction and oxidative stress in Alzheimer's disease, and Parkinson's disease, Huntington's disease and amyotrophic lateral sclerosis-an updated …

T Alqahtani, SL Deore, AA Kide, BA Shende, R Sharma… - Mitochondrion, 2023 - Elsevier
Misfolded proteins in the central nervous system can induce oxidative damage, which can
contribute to neurodegenerative diseases in the mitochondria. Neurodegenerative patients …

Mitochondrial dysfunction in microglia: A novel perspective for pathogenesis of Alzheimer's disease

Y Li, X Xia, Y Wang, JC Zheng - Journal of neuroinflammation, 2022 - Springer
Alzheimer's disease (AD) is the most common neurodegenerative disease in the elderly
globally. Emerging evidence has demonstrated microglia-driven neuroinflammation as a key …

Contribution of the Nrf2 pathway on oxidative damage and mitochondrial failure in Parkinson and Alzheimer's disease

F Villavicencio Tejo, RA Quintanilla - Antioxidants, 2021 - mdpi.com
The increase in human life expectancy has become a challenge to reduce the deleterious
consequences of aging. Nowadays, an increasing number of the population suffer from age …

Mitochondrial dysfunction in Alzheimer's disease: a biomarker of the future?

SM Bell, K Barnes, M De Marco, PJ Shaw, L Ferraiuolo… - Biomedicines, 2021 - mdpi.com
Alzheimer's disease (AD) is the most common cause of dementia worldwide and is
characterised pathologically by the accumulation of amyloid beta and tau protein …

Brain cells derived from Alzheimer's disease patients have multiple specific innate abnormalities in energy metabolism

WI Ryu, MK Bormann, M Shen, D Kim, B Forester… - Molecular …, 2021 - nature.com
Altered energy metabolism has been implicated both in aging and the pathogenesis of late-
onset Alzheimer's disease (LOAD). However, it is unclear which anomalies are acquired …

CD38 in neurodegeneration and neuroinflammation

S Guerreiro, AL Privat, L Bressac, D Toulorge - cells, 2020 - mdpi.com
Neurodegenerative diseases are characterized by neuronal degeneration as well as
neuroinflammation. While CD38 is strongly expressed in brain cells including neurons …

Sex and APOE ε4 genotype modify the Alzheimer's disease serum metabolome

M Arnold, K Nho, A Kueider-Paisley, T Massaro… - Nature …, 2020 - nature.com
Late-onset Alzheimer's disease (AD) can, in part, be considered a metabolic disease.
Besides age, female sex and APOE ε4 genotype represent strong risk factors for AD that …

Defining diurnal fluctuations in mouse choroid plexus and CSF at high molecular, spatial, and temporal resolution

RM Fame, PN Kalugin, B Petrova, H Xu… - Nature …, 2023 - nature.com
Transmission and secretion of signals via the choroid plexus (ChP) brain barrier can
modulate brain states via regulation of cerebrospinal fluid (CSF) composition. Here, we …